OBI PHARMA台灣浩鼎

Official YouTube channel for OBI Pharma Inc.

OBI Pharma, Inc. is a Taiwan-based bio pharma company founded in 2002 with the headquarter in Taipei and subsidiaries in the United States, China, Hong Kong and Australia. Our mission is to improve health and the quality of life of patients through innovative cancer therapeutics. We seek to develop and license novel therapeutic agents for unmet medical needs against cancers by targeting the Globo Series antigens (Globo H, SSEA-4), the AKR1C3 enzyme, and other promising targets.

OBI Pharma, Inc. is publicly listed on the Taipei Exchange (TPEx: 4174). The company is led by a management team with track records of success in new drug development and commercialization.